Alliance Pharma Share Discussion Threads

[baldrick1] 15/5/2024 11:11

Just seen it thanks ;)

[blackhorse23] 15/5/2024 10:53

Date on which the threshold was crossed or reached vi:10 May 2024

[blackhorse23] 15/5/2024 09:18

Pershing Nominees Limited and DouglasBay increasing their holdings

[tomzimerman] 15/5/2024 08:11

So you keep saying....yawning What time you topping up today ha ha

[blackhorse23] 15/5/2024 07:51

SP is going up , under valued stock , last year it was 100p

[bones698] 15/5/2024 00:49

Ceo departing and delayed results aren't usually a good sign. What next the cfo departing. Seems to me something not very nice is brewing here. Better to stay well clear for now imo

[tomzimerman] 14/5/2024 21:48

Tbh it has nothing to with the stock itself or the potential investment good or bad....but his idiotic comments and continuous spamming of other boards and his constant top ups. If I had a pound for every time he added more aph shares I'd be a very rich man now. Constantly trying to entice buyers for him to trade into is unethical imo and should be pointed out. Anyone following such comments seriously should not be investing full stop. IMHO

[seagreen] 14/5/2024 14:02

He called Currys right when everyone was slagging him off so even if you do not like his repetitive and wall papering posts and even if you do not like him

He can pick some right gooduns to...I think he has here to

[lawson27] 14/5/2024 13:56

1gw, you're wasting your time, he's an absolute plank, just filter him like everyone else does!

[blackhorse23] 14/5/2024 13:41

Something brewing , buyers are back

[blackhorse23] 14/5/2024 11:44

Last chance to BUY below 40p

[1gw] 14/5/2024 11:42

This is just in May. Give it a rest.
-----------------------------
Blackhorse23 - 14 May 2024 - 11:13:20 - 7289 of 7290 hVIVO plc - HVO
APH about to surge

Blackhorse23 - 14 May 2024 - 08:04:44 - 200 of 201 Light Science Technologies PLC: new vertical farming/agri-tech IPO - LST
Switched to APH

Blackhorse23 - 14 May 2024 - 08:04:19 - 639 of 647 Sondrel - SND
Money moved to APH

Blackhorse23 - 13 May 2024 - 10:14:08 - 24780 of 24801 ANGLE PLC - 2019 THREAD - LIQUID BIOPSY COMPANY - AGL
Money moved to APH ( alliance Pharma )

Blackhorse23 - 13 May 2024 - 10:12:29 - 9029 of 9040 British American Tobacco - BATS
Money moved to APH ( alliance Pharma )

Blackhorse23 - 13 May 2024 - 10:11:49 - 32933 of 32936 Glaxosmithkline - The recovery - GSK
Money moved to APH ( alliance Pharma )

Blackhorse23 - 13 May 2024 - 10:11:36 - 6031 of 6032 AstraZeneca - AZN
Money moved to APH ( alliance Pharma )

Blackhorse23 - 13 May 2024 - 10:11:07 - 13787 of 13802 Shield Therapeutics: poised for a US licensing deal - STX
Money moved to APH ( alliance Pharma )

Blackhorse23 - 13 May 2024 - 10:10:51 - 1610 of 1612 Respite for ARDS sufferers - FARN
Money moved to APH ( alliance Pharma )

Blackhorse23 - 10 May 2024 - 11:06:48 - 849 of 853 Plant Health Care; Using novel biological products in global markets - PHC
Money moved to APH

Blackhorse23 - 10 May 2024 - 11:06:23 - 3767 of 3830 Genedrive, A Game Changer for Point of Care Testing Market? - GDR
Money moved to APH

Blackhorse23 - 03 May 2024 - 10:55:15 - 7269 of 7290 hVIVO plc - HVO
Money moved to APH
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION

Blackhorse23 - 03 May 2024 - 10:53:49 - 6023 of 6032 AstraZeneca - AZN
Money moving to APH
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION

Blackhorse23 - 03 May 2024 - 10:52:38 - 21034 of 21134 FUTURA a winner for 2015 - FUM
Money moved to APH
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION

Blackhorse23 - 03 May 2024 - 10:52:12 - 579 of 618 O B I - OBI
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION

Blackhorse23 - 03 May 2024 - 10:51:35 - 3673 of 3830 Genedrive, A Game Changer for Point of Care Testing Market? - GDR
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION

Blackhorse23 - 03 May 2024 - 10:50:53 - 7759 of 7889 OXB. One owner, FSH Excellent conditionwith ejector seat - OXB
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION

Blackhorse23 - 03 May 2024 - 10:50:34 - 57646 of 57659 Avacta – Innovative and Disruptive Technologies for Global Health Markets - AVCT
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION

Blackhorse23 - 03 May 2024 - 10:49:35 - 57645 of 57659 Avacta – Innovative and Disruptive Technologies for Global Health Markets - AVCT
Yes mate , money moved to APH

Blackhorse23 - 02 May 2024 - 19:11:04 - 7744 of 7889 OXB. One owner, FSH Excellent conditionwith ejector seat - OXB
Some investors sold out here & bought APH ( alliance Pharma )

[seagreen] 14/5/2024 09:00

Potentially a minimum gain of circa 30% or more.
But WTFDWK blacky

[blackhorse23] 14/5/2024 07:57

Alliance Pharma plc (AIM: APH), the international healthcare group, announces its trading update for the year ended 31 December 2023 (the "Period"), ahead of the announcement of the Group's audited results in March 2024, which are anticipated to be in line with market expectations.Financial summaryThe Group delivered record see-through1 revenues in the Period of £182.7m (FY22: £172.0m), up 6% versus the prior period and up 7% at constant exchange rates ("CER"). Excluding sales from ScarAway and the US rights to Kelo-Cote in Q1 23, both acquired in March 2022 (the "US Acquisition"), like-for-like see-through revenues increased 6% CER. Continued strong consumer demand, particularly in China, drove significant recovery in Kelo-Cote franchise revenues in H2, leading to FY23 revenues of £63.2m, up 29% CER (FY22: £50.0m). Nizoral revenues increased 3% CER to £21.7m (FY22: £21.8m) whilst Amberen revenues declined 6% CER on an underlying basis (excluding the leading discount store account that was lost in 2022) and decreased 25% CER to £11.2m (FY22: £14.9m) on a reported basis. With Other Consumer brands up 5% CER to £40.3m (FY22: £38.4m), total see-through Consumer Healthcare revenues increased 11% CER to £136.4m. Prescription Medicine revenues were stable at £46.3m (FY22: £46.8m), reflecting a strong recovery in H2 as expected, as previously out of stock products became available. Underlying profit for the Period is anticipated to be in-line with market expectations.

[diku] 13/5/2024 22:22

CURYman is here?...

[mattboxy] 13/5/2024 18:05

Get out while you can. Moneys moving anywhere but here!!

[blackhorse23] 13/5/2024 16:00

Likely sudden dividend announcement

[buoycat] 13/5/2024 15:38

CEO departs. Results delayed, and delayed again. I'm a holder, but certainly not the time to be topping saying everything is rosy. All we need now is for the shares to be suddenly suspended...

[wad collector] 13/5/2024 15:24

If you are so confident this will rise, why do you continue to plaster the advfn site with claims you are selling other shares to buy here?

[blackhorse23] 13/5/2024 11:39

expecting results: record see-through revenues of ?182.7m (FY22: ?172.0m)?~Continued strong consumer demand?~Free cash flow in the Period rose 34% to ?21.1m (FY22: ?15.8m)HSBC upgraded to BUY few weeks ago

[blackhorse23] 13/5/2024 11:38

Buyers are back lol

[blackhorse23] 13/5/2024 11:38

U still in bed lol